PEDRO ARNALDO MASCARO

Dr. PEDRO ARNALDO MASCARO


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DMDavid Mauricio
David Mauricio
JCJorge Cárdenas-Grandez
Jorge Cárdenas-Grandez
GGGiuliana Vanessa Uribe Godoy
Giuliana Vanessa Uribe Godoy
Mirko Jerber Rodríguez MallmaMirko Jerber Rodríguez Mallma
Mirko Jerber Rodríguez Mallma
NMNelson Maculan
Nelson Maculan
PMPEDRO ARNALDO MASCARO
PEDRO ARNALDO MASCARO
Background: Pediatric and congenital heart surgery (PCHS) is highly risky. Complications associated with this surgical procedure are mainly caused by the severity of the disease or the unnecessary, late, or premature execution of the procedure, which can be fatal. In this context, prognostic models are crucial to reduce the uncertainty of the decision to perform surgery; however, these models alone are insufficient to maximize the probability of success or to reverse a future scenario of patient death. Method: A new approach is proposed to reverse the prognosis of death in PCHS through the use of (1) machine learning (ML) models to predict the outcome of surgery; (2) an explainability technique (ET) to determine the impact of main risk factors; and (3) a simulation method to design health scenarios that potentially reverse a negative prognosis. Results: Accuracy levels of 96% in the prediction of mortality and survival were achieved using a dataset of 565 patients undergoing PCHS and assessing 10 risk factors. Three case studies confirmed that the ET known as LIME provides explanations that are consistent with the observed results, and the simulation of one real case managed to reverse the initial prognosis of death to one of survival. Conclusions: An innovative method that integrates ML models, ETs, and Simulation has been developed to reverse the prognosis of death in patients undergoing PCHS. The experimental results validate the relevance of this approach in medical decision-making, demonstrating its ability to reverse negative prognoses and provide a solid basis for more informed and personalized medical decisions.